MedPath

Pilot study to investigate the efficacy of rapamycin topical medicine against intractable hyperhidrosis

Not Applicable
Recruiting
Conditions
hyperhidrosis
Registration Number
JPRN-UMIN000015874
Lead Sponsor
Department of Dermatology Graduate School of Medicine, Osaka University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
3
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who cannot carry out this treatment plan. 2) Patients who have allergy to macrolide antibiotics. 3) Patients who received oral or topical administration of rapamycin or RAD001 within 12 months prior to the study entry. 4) Patients who received topical treatment of aluminum chloride or iontophoresis within one months prior to the study entry. 5) Patients who received local injection of Botox within three months prior to the study entry. 6) Patients who received sympathectomy within 12 months prior to the study entry. 7) Patients during pregnancy or lactation 8) Patients who cannot undergo QSART and starch-iodine test 9) Patients who were judged unsuitable for this study by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath